Antibiotic susceptibility and molecular epidemiology of nasopharyngeal pneumococci from Spanish children

Clinical Microbiology and Infection

Volumn 14, Issue 8, 2008, Pages 797-801

  Sanchez Tatay D ^a   Arroyo, L A ^a   Tarrago D ^b   Lirola, M J ^c   Porras, A ^a   Fenoll, A ^b   Hausdorff, W P ^d   Brueggemann, A B ^e   Obando, I ^a,f  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

^d GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f University of Oxford ^*  (Spain)

Author keywords

Epidemiology; Molecular; Nasopharyngeal carriage; Streptococcus pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; EMERGENCY WARD; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRESCHOOL CHILD; PRIMARY HEALTH CARE; PRIORITY JOURNAL; RHINOPHARYNGITIS; SEROTYPE; SPAIN; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

EID: 48449094939     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2008.02025.x     Document Type: Review

References (21)

1. Kyaw MH, Lynfield R, Schaffner W et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006; 354: 1455-1463.
2. Stephens DS, Zughaier SM, Whitney CG et al. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: Population-based assessment. Lancet 2005; 365: 855-863.
3. Huang SS, Platt R, Rifas-Shiman SL, Pelton SI, Goldmann D, Finkelstein JA. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 2005; 116: e408-e413.
4. Temime L, Guillemot D, Boelle PY. Short- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistance. Antimicrob Agents Chemother 2004; 48: 2206-2213.
5. Hanage WP, Huang SS, Lipsitch M et al. Post-PCV7 changes in antibiotic resistance among nonvaccine pneumococcal strains in 16 Massachusetts communities. J Infect Dis 2007; 195: 347-352.
6. O'Brien KL, Nohynek H, the WHO pneumococcal vaccine trials carriage working group. Report from a WHO working group: Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J 2003; 22: E1-e11.
7. Fenoll A, Jado I, Vicioso D, Casal J. Dot blot assay for the serotyping of pneumococci. J Clin Microbiol 1997; 35: 764-766.
8. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility test for bacteria that growth aerobically, 7th 371 edn. Approved standard M7-A6. Wayne, PA: Clinical and Laboratory Standards Institute, 2003.
9. Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 1996; 40: 2562-2566.
10. Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: Identification of clones associated with serious invasive disease. Microbiology 1998; 144: 3049-3060.
11. Garcia-de-Lomas J, Gimeno C, Millas C et al. Antimicrobial susceptibility of Streptococcus pneumoniae isolated from pediatric carriers in Spain. Eur J Clin Microbiol Infect Dis 1997; 16: 11-13.
12. Lopez B, Cima MD, Vazquez F et al. Epidemiological study of Streptococcus pneumoniae carriers in healthy primary-school children. Eur J Clin Microbiol Infect Dis 1999; 18: 771-776.
13. Pallares R, Fenoll A, Liñares J. The epidemiology of antibiotic resistance in Streptococcus pneumoniae and the clinical relevance of resistance to cephalosporins, macrolides and quinolones. Int J Antimicrob Agents 2003; 22(suppl): 15-24.
14. Pérez-Trallero E, García de la Fuente C, García-Rey C et al. Geographical and ecological analysis of resistance, coresistance and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain. Antimicrob Agents Chemother 2005; 49: 1965-1972.
15. European Antimicrobial Resistance Surveillance System. Annual report 2005. October 2006, posting date. Chapter 4.2.2, Streptococcus pneumoniae resistance trends: 1999-2005. http://www.rivm.nl/earss/Images/ EARSS%202005_tcm61-34899.pdf.
16. Oteo J, Lázaro E, De Abajo FJ, Baquero F, Campos J,
17. Spanish members of the European Antimicrobial Resistance Surveillance System. Trends in antimicrobial resistance in 1968 invasive Streptococcus pneumoniae strains isolated in Spanish hospitals (2001-2003): Decreasing penicillin resistance in children's isolates. J Clin Microbiol 2004; 42: 5571-5577.
18. Fenoll A, Asensio G, Jado I et al. Antimicrobial susceptibility and pneumococcal serotypes. J Antimicrob Chemother 2002; 50(suppl 2): 13-19.
19. Benito-Fernández J, Raso SM, Pocheville-Gurutzeta I, SánchezEtxaniz J, Azcunaga-Santibañez B, Capapé-Zache S. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain. Pediatr Infect Dis J 2007; 26: 667-671.
20. Muñoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, Pallares R. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2008; 46: 174-182.
21. Obando I, Arroyo LA, Sánchez-Tatay D et al. Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine. Clin Microbiol Infect 2007; 13: 347-348.